The report provides a detailed analysis essential for establishing a Gepirone production plant. It encompasses all critical aspects necessary for Gepirone production, including the cost of Gepirone production, Gepirone plant cost, Gepirone production costs, and the overall Gepirone production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Gepirone production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Gepirone is authorized for the treatment of major depressive disorder (MDD) in adults. It functions by focusing on particular serotonin receptors in the brain, which lifts depressive symptoms and elevates mood. It is a pharmaceutical analog of buspirone. Gepirone preferentially binds to pre- and post-synaptic 5HT1A receptors. It functions as an anxiolytic, an antidepressant, and a serotonergic agonist.
The procurement of Gepirone is influenced by its application in the pharmaceutical and medical industries as an antidepressant medication. The use of Gepirone has been demanded more since cases of depressive symptoms are rising. Gepirone has fewer typical antidepressant side effects like weight gain and sexual dysfunction.
When the drug is given as an extended-release tablet, it releases consistently throughout time, potentially increasing its effectiveness. According to clinical research, Gepirone considerably inhibits depressive symptoms when compared to a placebo, making it a viable treatment choice for people who are depressed. Gepirone is the first and only antidepressant that has been approved that specifically targets serotonin 1A receptors, which are important for mood and emotion regulation.
Its distinct mechanism of action sets it apart from other antidepressants, thus increasing its demand. Overall, industrial Gepirone procurement is influenced by its application in the pharmaceutical and medical industries as an antidepressant, rising cases of major depressive disorders, fewer side effects, better tolerability, clinical research results, increased effectiveness, distinct mechanism of action, increased mental health awareness, and regulatory approvals.
Raw Material for Gepirone Production
According to the Gepirone production plant project report, the key raw material used in the production of Gepirone includes 2-(piperazin-1-yl)pyrimidine.
Manufacturing Process of Gepirone
The extensive Gepirone production cost report consists of the following major industrial production process:
- Production from 2-(piperazin-1-yl)pyrimidine: The production process of Gepirone starts with the reaction of 2-(piperazin-1-yl)pyrimidine with 1,4-dibromobutane in the presence of Na2CO3 and isopropanol to form an intermediate. The intermediate is subjected to ring opening followed by an addition reaction in the presence of K2CO3 and dimethylformamide to produce Gepirone.
Gepirone is commercially known as Exxua. It has the molecular formula C19H29N5O2 and a molecular weight of 359.5 g/mol. It has a water solubility of 1.09 mg/mL. It has a log P value of 2.09. The value of its dissociation constant, pKa, is 7.62. It dissolves to some extent in chloroform and methanol. It should be stored in an inert atmosphere (such as nitrogen or argon) at a temperature of 2 to 8°C to keep it stable. Gepirone belongs to the class of piperidones, which are derivatives of piperidine-2,6-dione modified at position 1 and position 4 with two methyl groups and a 4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl group. It functions as a serotonin receptor agonist used to treat major depressive disorders in adults.
